Position in TMO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,342,567
+$158,928 QoQ
Shares Held
6,667
+2.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#973
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ELLERSON GROUP INC /ADV holds $6,109,289 across 2 Diagnostics & Research names. TMO ranks #1 (54.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
6,667 | $3,342,567 | |
| 2 | DHR |
Danaher Corp /De/
|
14,525 | $2,766,722 |
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,342,567 | 6,667 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,183,639 | 6,477 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,775,696 | 6,516 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,184,156 | 6,565 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,633,057 | 6,494 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,166,726 | 6,364 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,263,923 | 6,274 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,038,024 | 6,528 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,712,289 | 6,713 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $3,964,433 | 6,821 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,822,218 | 7,201 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,529,523 | 6,973 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,636,075 | 6,969 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,016,722 | 6,969 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,842,164 | 6,977 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||